Dapagliflozin: a sodium–glucose cotransporter 2 inhibitor, attenuates angiotensin II-induced cardiac fibrotic remodeling by regulating TGFβ1/Smad signaling

Overview of attention for article published in Cardiovascular Diabetology, June 2021

Altmetric Badge

Mentioned by

So far, Altmetric has seen 1 X post from an account with 4,358 followers.

【備忘】 Cardiovasc Diabetol誌に、アンジオテンシンII持続注入による心筋肥大と線維化を、SGLT2阻害薬が抑制するという、ラットを用いた成績。血糖値、血圧には変化なし。 https://t.co/F5EfLodKTg

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.